Trial Profile
Observational Sentinel Sites Study in Infants Younger Than 12 Months Who Are Prescribed Treatment With Keppra (Levetiracetam) Oral Solution in Usual Clinical Practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Acronyms PASS
- Sponsors UCB
- 01 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2013 Planned End Date changed from 1 Feb 2014 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 14 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.